We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Philip Morris
PM
$312B
| $456M | 0.16% |
2,517,931
-391,103
| -13% | -$67.8M |
2013 Q2
52 quarters
|
|
152
Datadog
DDOG
$92.1B
| $455M | 0.16% |
1,798,627
-762,437
| -30% | -$142M |
2022 Q1
17 quarters
|
|
153
NNN REIT
NNN
$7.98B
| $455M | 0.16% |
9,773,107
+5,915,740
| +153% | +$264M |
2013 Q2
52 quarters
|
|
154
AXIS Capital
AXS
$7.33B
| $454M | 0.16% |
4,229,033
-702,946
| -14% | -$70.5M |
2021 Q1
21 quarters
|
|
155
Applied Industrial Technologies
AIT
$12.2B
| $452M | 0.16% |
1,343,397
+423,786
| +46% | +$130M |
2021 Q2
20 quarters
|
|
156
Accenture
ACN
$146B
| $451M | 0.16% |
3,657,820
+2,596,312
| +245% | +$451M |
2014 Q4
46 quarters
|
|
157
Burlington
BURL
$16.3B
| $450M | 0.16% |
1,450,868
+112,609
| +8% | +$36.3M |
2023 Q1
13 quarters
|
|
158
CME Group
CME
$106B
| $448M | 0.16% |
2,027,267
+45,168
| +2% | +$12.5M |
2013 Q2
52 quarters
|
|
159
Chemed
CHE
$6.75B
| $446M | 0.16% |
972,474
+556,862
| +134% | +$234M |
2013 Q2
52 quarters
|
|
160
Pfizer
PFE
$172B
| $445M | 0.16% |
18,557,891
+6,678,656
| +56% | +$175M |
2013 Q2
52 quarters
|
|
161
HubSpot
HUBS
$12.5B
| $441M | 0.15% |
2,418,126
+789,957
| +49% | +$165M |
2020 Q3
23 quarters
|
|
162
Landstar System
LSTR
$5.77B
| $439M | 0.15% |
2,122,575
+286,971
| +16% | +$54.9M |
2013 Q2
52 quarters
|
|
163
Molson Coors Class B
TAP
$7.5B
| $433M | 0.15% |
11,108,304
+6,412,705
| +137% | +$268M |
2013 Q2
52 quarters
|
|
164
Marsh
MRSH
$91.3B
| $432M | 0.15% |
2,607,451
-1,066,536
| -29% | -$178M |
2013 Q2
52 quarters
|
|
165
Dow Inc
DOW
$22.2B
| $430M | 0.15% |
15,698,239
+5,381,487
| +52% | +$195M |
2020 Q4
22 quarters
|
|
166
Toro Company
TTC
$9.7B
| $429M | 0.15% |
4,421,337
-115,188
| -3% | -$10.7M |
2024 Q3
7 quarters
|
|
167
Altria Group
MO
$125B
| $427M | 0.15% |
5,940,353
+610,528
| +11% | +$42.6M |
2013 Q2
52 quarters
|
|
168
Target
TGT
$70B
| $427M | 0.15% |
3,272,679
+308,965
| +10% | +$39.3M |
2013 Q2
52 quarters
|
|
169
Colgate-Palmolive
CL
$75.4B
| $427M | 0.15% |
4,665,294
+2,886,409
| +162% | +$253M |
2013 Q2
52 quarters
|
|
170
Western Alliance Bancorporation
WAL
$8.22B
| $423M | 0.15% |
5,151,917
+4,244,622
| +468% | +$335M |
2019 Q4
26 quarters
|
|
171
Textron
TXT
$13.3B
| $423M | 0.15% |
4,658,243
-975,033
| -17% | -$88.6M |
2013 Q2
52 quarters
|
|
172
Jefferies Financial Group
JEF
$10.3B
| $421M | 0.15% |
8,426,996
+3,144,305
| +60% | +$162M |
2020 Q2
24 quarters
|
|
173
nVent Electric
NVT
$22.6B
| $420M | 0.15% |
2,523,257
+455,512
| +22% | +$71M |
2018 Q2
32 quarters
|
|
174
Stifel
SF
$10.1B
| $419M | 0.15% |
6,001,400
-2,468,463
| -29% | -$184M |
2017 Q1
37 quarters
|
|
175
Biogen
BIIB
$35.9B
| $417M | 0.15% |
1,936,859
+13,302
| +0.7% | +$2.54M |
2013 Q2
52 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.